Europe — EMA

Nyvepria (Pegfilgrastim)

Pegfilgrastim, the active ingredient in Nyvepria, is a colony-stimulating factor presented as a unknown/unknown for subcutaneous use. It reduces the duration of neutropenia and related infection risk in patients…

Pegfilgrastim

Request sourcing

Pack/s

What is Pegfilgrastim?

GNH USA supplies Nyvepria as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Pegfilgrastim used for?

Nyvepria is a hematopoietic growth factor that operates ... ... .... .... .... .... ... .... .... .... ... .... ... .... .... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →